News

New research identifies VLCFA metabolism as a target to boost multiple myeloma treatment efficacy and combat drug resistance.

A new study has confirmed that type 2 diabetes significantly increases the risk of major cardiovascular events, regardless of atherosclerosis severity.

New data from the COVAIL trial highlight the importance of neutralizing antibody titers in reducing COVID-19 risk after mRNA boosters, with stronger protection observed in individuals with prior SARS-CoV-2 infection.

A clinical trial was conducted to evaluate the efficacy and safety of autologous HBV vaccine-pulsed dendritic cells and their induced T cells.

Heavy alcohol consumption, particularly binge drinking, is a significant risk factor for cryptogenic ischaemic stroke in young men.

A new study shows that biologic treatments significantly reduce inflammation and improve jaw function in children with juvenile idiopathic arthritis (JIA) affecting the temporomandibular joint (TMJ).

Severe maternal morbidity risk is five times higher with preeclampsia, underscoring the need for prevention in chronic hypertension.

AI foundation models boost ovarian carcinoma subtyping accuracy, providing clinicians with valuable diagnostic support and efficiency.